Nouvelle déclaration d'incident
No de la demande: 2019-6276
Numéro de référence du titulaire d'homologation: 2019-CA-000155
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez l'humain
Pays: CANADA
État: QUEBEC
ARLA No d'homologation 31724 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Hartz UltraGuard Rid Flea Dog Shampoo - Fresh Scent
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Inconnu
Personne affectée
Sexe: Femme
Âge: >19 <=64 yrs / >19 <=64 ans
Système
Unknown / Inconnu
Non
Non
Non professionnel
Application
Gants résistants aux produits chimiques
Peau
>15 min <=2 hrs / >15 min <=2 h
Unknown / Inconnu
On approximately 16-Oct-2019, a x year old, 100 pound, female, human, in unknown condition, with concomitant medical conditions COPD, peptic ulcers, acid reflux, who smokes, has allergies to grass, trees, and dust, and who takes Spiriva (tiotropium), Alvesco (ciclesonide), an albuterol inhaler, and an unknown medication for acid reflux, was exposed to an unknown amount of Hartz UltraGuard Rid Flea Dog Shampoo Fresh Scent (Phenothrin) while bathing her dog with the product. The woman wore gloves while bathing the dog, then removed them while blow drying the dog. An unspecified amount of time later, she began to experience gagging, dry heaves (retching), pain in her abdominal muscles, and dyspnea. She treated her symptoms herself by taking unspecified amounts of her normal medications, and continued to be symptomatic at the time of the call (26-Oct-2019). Follow-up was attempted but no further information was received in this case.
Modérée
Assessment: This product is considered to have a wide margin of safety due to the low concentration of pyrethroid present. If dermal exposure occurs, skin irritation and a temporary tingling sensation may occur. The signs described in this case and their prolonged duration are not expected and are more likely related to underlying medical conditions, though individual sensitivities may exist. The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.